12:00 AM
Nov 22, 1999
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Symphar preclinical data

Symphar presented results from a mouse model of bone metastases from breast cancer in which the number and size of metastases were reduced in a dose-dependent...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >